Trials / Completed
CompletedNCT04147260
Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin
Partially-blind, Randomized, Parallel Group, Placebo and Active Comparator-controlled Phase I Clinical Trial to Evaluate the Photosensitivity Potential of BI 730357
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the photosensitivity potential of BI 730357
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 730357 | Film-coated tablet |
| DRUG | Placebo to match BI 730357 | Film-coated tablet |
| DRUG | Ciprofloxacin | Film-coated tablet |
Timeline
- Start date
- 2019-11-06
- Primary completion
- 2020-09-09
- Completion
- 2020-09-09
- First posted
- 2019-11-01
- Last updated
- 2023-07-17
- Results posted
- 2023-07-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04147260. Inclusion in this directory is not an endorsement.